Boule Diagnostics AB (publ) (STO:BOUL)
Sweden · Delayed Price · Currency is SEK 5.70
-0.10 (-1.72%)
Sep 18, 2025, 4:58 PM CET
Boule Diagnostics AB Market Cap
Boule Diagnostics AB has a market cap or net worth of 225.23 million as of September 18, 2025. Its market cap has decreased by -32.71% in one year.
Market Cap
225.23M
Enterprise Value
409.93M
Revenue
515.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.70
Market Cap Chart
Since June 23, 2011, Boule Diagnostics AB's market cap has increased from 162.45M to 225.23M, an increase of 38.65%. That is a compound annual growth rate of 2.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 225.23M | -35.41% |
| Dec 30, 2024 | 348.72M | -19.96% |
| Dec 29, 2023 | 435.71M | -25.70% |
| Dec 30, 2022 | 586.38M | -38.11% |
| Dec 30, 2021 | 947.53M | -17.98% |
| Dec 30, 2020 | 1.16B | -12.76% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 94.86B |
| Sectra AB | 60.07B |
| Getinge AB | 57.72B |
| Camurus AB | 41.24B |
| Medicover AB | 39.10B |
| Asker Healthcare Group AB | 36.24B |
| BioArctic AB | 23.93B |
| AddLife AB | 23.63B |